Baloxavir is a medicine used to treat the flu and to help prevent it after you've been around someone who has it. It works by stopping the flu virus from copying itself in your body. It's taken by mouth as a single dose, as a tablet or a liquid.
Every report comes from a Lived member, sent anonymously.
Have you tried Xofluza (Baloxavir Marboxil) for Flu?
Baloxavir marboxil, sold as Xofluza, is a prescription antiviral medicine for influenza (the flu). It is approved to treat uncomplicated flu in people 5 years and older who have had symptoms for no more than 48 hours, whether they are otherwise healthy or at higher risk of flu complications, such as people with asthma, diabetes or heart disease, or adults 65 and older. It is also approved to prevent flu in people 5 and older after close contact with someone who has it, such as a sick member of the household. Its main difference from oseltamivir (Tamiflu), the most widely used flu antiviral, is convenience: Xofluza is a single dose rather than pills twice a day for five days. It is not used in children under 5, because the virus more often becomes resistant to it in young children. US health authorities do not routinely recommend it for people sick enough to be in the hospital, or as the only antiviral for people with severely weakened immune systems, because it has not been shown to work well in hospital patients, and in people with very weak immune systems the virus is more likely to become resistant.
Flu viruses can only multiply by taking over cells in the airways and making copies of themselves. To do that, the virus uses an enzyme to snip a small piece from the cell's own genetic messages and use it to start reading its own genes. Baloxavir blocks that enzyme, so the virus cannot make the proteins it needs and stops multiplying. Baloxavir marboxil is a prodrug, meaning the body converts it into the active form, baloxavir, after it is swallowed. A single dose is the full course of treatment. Because it acts on the virus while it is still multiplying, it helps most when taken early in the illness, and it does nothing against colds, COVID-19 or bacterial infections.
Xofluza is taken once, as a single dose, as soon as possible after flu symptoms start or after being exposed, and within 48 hours. The dose depends on body weight: most people take one tablet, either 40 mg or 80 mg. A liquid form is approved for people who cannot swallow tablets, though US availability of the liquid has been limited. It can be taken with or without food, but not together with milk or other dairy foods, calcium-fortified drinks, antacids or certain laxatives, or with supplements containing calcium, iron, magnesium, selenium or zinc. These bind to the medicine in the gut and can keep enough of it from being absorbed.
Most people have no noticeable side effects. In clinical trials the most common were diarrhea, nausea and headache, and these occurred about as often in people given a placebo. Children 5 to 11 sometimes had vomiting or diarrhea. Rarely, baloxavir causes a serious allergic reaction. Trouble breathing, or swelling of the face, lips, tongue or throat, needs emergency care right away (call 911). Hives or a new widespread rash, including a blistering or target-shaped rash, should be checked by a clinician the same day. Anyone who has had an allergic reaction to baloxavir should not take it again.
The most practical interaction is the one with dairy, antacids and mineral supplements such as calcium, iron or zinc, described under Dosage & Administration. A pharmacist can help plan when to restart those products. Flu antivirals can make the nasal-spray flu vaccine, which contains weakened live virus, less effective. Tell the person giving a flu vaccine about recent Xofluza use, since a flu shot may be the better choice for now. Interactions with flu shots have not been studied. There are no human studies of baloxavir in pregnancy or breastfeeding, and the Centers for Disease Control and Prevention (CDC) does not recommend it for treating flu during either. Because pregnant people are at higher risk of severe flu, they should ask their clinician about a different flu antiviral rather than going without treatment.
In trials of otherwise healthy people 12 and older, flu symptoms typically eased in about two and a quarter days with Xofluza, compared with about three and a third days with a placebo, roughly a day sooner. In adults, that was the same as five days of oseltamivir. People at higher risk of complications saw a similar gain of about a day. Baloxavir has not been shown to prevent flu complications. Bacterial infections such as pneumonia or ear and sinus infections can follow the flu and are not treated by an antiviral. Symptoms that do not ease, or that improve and then come back (such as a returning fever or cough), are a reason to contact a clinician for a fresh assessment rather than another dose. Trouble breathing or shortness of breath needs medical care right away. Flu viruses change from year to year, and some strains can become less sensitive to baloxavir, more often in children. Prescribers take local resistance patterns into account when choosing an antiviral, which is one reason a different one may be recommended in some seasons.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Xofluza (Baloxavir Marboxil), what you've noticed, or ask the community a question.